Global Filgrastim Injection Market Growth 2024-2030

Product Code: 978336

Industry: Pharma & Healthcare

Published: Jan 09,2024

Pages: 94

Delivery Time: 2-3 business days

Global Filgrastim Injection Market Growth 2024-2030

Product Code: 978336

Industry: Pharma & Healthcare

Published: Jan 09,2024

Pages: 94

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to our LPI (LP Information) latest study, the global Filgrastim Injection market size was valued at US$ million in 2023. With growing demand in downstream market, the Filgrastim Injection is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Filgrastim Injection market. Filgrastim Injection are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Filgrastim Injection. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Filgrastim Injection market.

Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.

Key Features:
The report on Filgrastim Injection market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Filgrastim Injection market. It may include historical data, market segmentation by Type (e.g., 300mcg/mL (vial), 480mcg/1.6 mL (vial)), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Filgrastim Injection market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Filgrastim Injection market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Filgrastim Injection industry. This include advancements in Filgrastim Injection technology, Filgrastim Injection new entrants, Filgrastim Injection new investment, and other innovations that are shaping the future of Filgrastim Injection.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Filgrastim Injection market. It includes factors influencing customer ' purchasing decisions, preferences for Filgrastim Injection product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Filgrastim Injection market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Filgrastim Injection market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Filgrastim Injection market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Filgrastim Injection industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Filgrastim Injection market.

Market Segmentation:
Filgrastim Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
300mcg/mL (vial)
480mcg/1.6 mL (vial)
300mcg/0.5mL (Prefilled Syringe)
480mcg/0.8mL (Prefilled Syringe)

Segmentation by application
Adult Use
Pediatric Use
Geriatric Use

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Accord Healthcare
Teva Pharmaceuticals
Pfizer
Amgen Inc
Novartis AG

Key Questions Addressed in this Report
What is the 10-year outlook for the global Filgrastim Injection market?
What factors are driving Filgrastim Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Filgrastim Injection market opportunities vary by end market size?
How does Filgrastim Injection break out type, application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Filgrastim Injection Annual Sales 2019-2030
        2.1.2 World Current & Future Analysis for Filgrastim Injection by Geographic Region, 2019, 2023 & 2030
        2.1.3 World Current & Future Analysis for Filgrastim Injection by Country/Region, 2019, 2023 & 2030
    2.2 Filgrastim Injection Segment by Type
        2.2.1 300mcg/mL (vial)
        2.2.2 480mcg/1.6 mL (vial)
        2.2.3 300mcg/0.5mL (Prefilled Syringe)
        2.2.4 480mcg/0.8mL (Prefilled Syringe)
    2.3 Filgrastim Injection Sales by Type
        2.3.1 Global Filgrastim Injection Sales Market Share by Type (2019-2024)
        2.3.2 Global Filgrastim Injection Revenue and Market Share by Type (2019-2024)
        2.3.3 Global Filgrastim Injection Sale Price by Type (2019-2024)
    2.4 Filgrastim Injection Segment by Application
        2.4.1 Adult Use
        2.4.2 Pediatric Use
        2.4.3 Geriatric Use
    2.5 Filgrastim Injection Sales by Application
        2.5.1 Global Filgrastim Injection Sale Market Share by Application (2019-2024)
        2.5.2 Global Filgrastim Injection Revenue and Market Share by Application (2019-2024)
        2.5.3 Global Filgrastim Injection Sale Price by Application (2019-2024)

3 Global Filgrastim Injection by Company
    3.1 Global Filgrastim Injection Breakdown Data by Company
        3.1.1 Global Filgrastim Injection Annual Sales by Company (2019-2024)
        3.1.2 Global Filgrastim Injection Sales Market Share by Company (2019-2024)
    3.2 Global Filgrastim Injection Annual Revenue by Company (2019-2024)
        3.2.1 Global Filgrastim Injection Revenue by Company (2019-2024)
        3.2.2 Global Filgrastim Injection Revenue Market Share by Company (2019-2024)
    3.3 Global Filgrastim Injection Sale Price by Company
    3.4 Key Manufacturers Filgrastim Injection Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Filgrastim Injection Product Location Distribution
        3.4.2 Players Filgrastim Injection Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Filgrastim Injection by Geographic Region
    4.1 World Historic Filgrastim Injection Market Size by Geographic Region (2019-2024)
        4.1.1 Global Filgrastim Injection Annual Sales by Geographic Region (2019-2024)
        4.1.2 Global Filgrastim Injection Annual Revenue by Geographic Region (2019-2024)
    4.2 World Historic Filgrastim Injection Market Size by Country/Region (2019-2024)
        4.2.1 Global Filgrastim Injection Annual Sales by Country/Region (2019-2024)
        4.2.2 Global Filgrastim Injection Annual Revenue by Country/Region (2019-2024)
    4.3 Americas Filgrastim Injection Sales Growth
    4.4 APAC Filgrastim Injection Sales Growth
    4.5 Europe Filgrastim Injection Sales Growth
    4.6 Middle East & Africa Filgrastim Injection Sales Growth

5 Americas
    5.1 Americas Filgrastim Injection Sales by Country
        5.1.1 Americas Filgrastim Injection Sales by Country (2019-2024)
        5.1.2 Americas Filgrastim Injection Revenue by Country (2019-2024)
    5.2 Americas Filgrastim Injection Sales by Type
    5.3 Americas Filgrastim Injection Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Filgrastim Injection Sales by Region
        6.1.1 APAC Filgrastim Injection Sales by Region (2019-2024)
        6.1.2 APAC Filgrastim Injection Revenue by Region (2019-2024)
    6.2 APAC Filgrastim Injection Sales by Type
    6.3 APAC Filgrastim Injection Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Filgrastim Injection by Country
        7.1.1 Europe Filgrastim Injection Sales by Country (2019-2024)
        7.1.2 Europe Filgrastim Injection Revenue by Country (2019-2024)
    7.2 Europe Filgrastim Injection Sales by Type
    7.3 Europe Filgrastim Injection Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Filgrastim Injection by Country
        8.1.1 Middle East & Africa Filgrastim Injection Sales by Country (2019-2024)
        8.1.2 Middle East & Africa Filgrastim Injection Revenue by Country (2019-2024)
    8.2 Middle East & Africa Filgrastim Injection Sales by Type
    8.3 Middle East & Africa Filgrastim Injection Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Filgrastim Injection
    10.3 Manufacturing Process Analysis of Filgrastim Injection
    10.4 Industry Chain Structure of Filgrastim Injection

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Filgrastim Injection Distributors
    11.3 Filgrastim Injection Customer

12 World Forecast Review for Filgrastim Injection by Geographic Region
    12.1 Global Filgrastim Injection Market Size Forecast by Region
        12.1.1 Global Filgrastim Injection Forecast by Region (2025-2030)
        12.1.2 Global Filgrastim Injection Annual Revenue Forecast by Region (2025-2030)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Filgrastim Injection Forecast by Type
    12.7 Global Filgrastim Injection Forecast by Application

13 Key Players Analysis
    13.1 Accord Healthcare
        13.1.1 Accord Healthcare Company Information
        13.1.2 Accord Healthcare Filgrastim Injection Product Portfolios and Specifications
        13.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.1.4 Accord Healthcare Main Business Overview
        13.1.5 Accord Healthcare Latest Developments
    13.2 Teva Pharmaceuticals
        13.2.1 Teva Pharmaceuticals Company Information
        13.2.2 Teva Pharmaceuticals Filgrastim Injection Product Portfolios and Specifications
        13.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.2.4 Teva Pharmaceuticals Main Business Overview
        13.2.5 Teva Pharmaceuticals Latest Developments
    13.3 Pfizer
        13.3.1 Pfizer Company Information
        13.3.2 Pfizer Filgrastim Injection Product Portfolios and Specifications
        13.3.3 Pfizer Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.3.4 Pfizer Main Business Overview
        13.3.5 Pfizer Latest Developments
    13.4 Amgen Inc
        13.4.1 Amgen Inc Company Information
        13.4.2 Amgen Inc Filgrastim Injection Product Portfolios and Specifications
        13.4.3 Amgen Inc Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.4.4 Amgen Inc Main Business Overview
        13.4.5 Amgen Inc Latest Developments
    13.5 Novartis AG
        13.5.1 Novartis AG Company Information
        13.5.2 Novartis AG Filgrastim Injection Product Portfolios and Specifications
        13.5.3 Novartis AG Filgrastim Injection Sales, Revenue, Price and Gross Margin (2019-2024)
        13.5.4 Novartis AG Main Business Overview
        13.5.5 Novartis AG Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Filgrastim Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Table 2. Filgrastim Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
    Table 3. Major Players of 300mcg/mL (vial)
    Table 4. Major Players of 480mcg/1.6 mL (vial)
    Table 5. Major Players of 300mcg/0.5mL (Prefilled Syringe)
    Table 6. Major Players of 480mcg/0.8mL (Prefilled Syringe)
    Table 7. Global Filgrastim Injection Sales by Type (2019-2024) & (KL)
    Table 8. Global Filgrastim Injection Sales Market Share by Type (2019-2024)
    Table 9. Global Filgrastim Injection Revenue by Type (2019-2024) & ($ million)
    Table 10. Global Filgrastim Injection Revenue Market Share by Type (2019-2024)
    Table 11. Global Filgrastim Injection Sale Price by Type (2019-2024) & (US$/L)
    Table 12. Global Filgrastim Injection Sales by Application (2019-2024) & (KL)
    Table 13. Global Filgrastim Injection Sales Market Share by Application (2019-2024)
    Table 14. Global Filgrastim Injection Revenue by Application (2019-2024)
    Table 15. Global Filgrastim Injection Revenue Market Share by Application (2019-2024)
    Table 16. Global Filgrastim Injection Sale Price by Application (2019-2024) & (US$/L)
    Table 17. Global Filgrastim Injection Sales by Company (2019-2024) & (KL)
    Table 18. Global Filgrastim Injection Sales Market Share by Company (2019-2024)
    Table 19. Global Filgrastim Injection Revenue by Company (2019-2024) ($ Millions)
    Table 20. Global Filgrastim Injection Revenue Market Share by Company (2019-2024)
    Table 21. Global Filgrastim Injection Sale Price by Company (2019-2024) & (US$/L)
    Table 22. Key Manufacturers Filgrastim Injection Producing Area Distribution and Sales Area
    Table 23. Players Filgrastim Injection Products Offered
    Table 24. Filgrastim Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Filgrastim Injection Sales by Geographic Region (2019-2024) & (KL)
    Table 28. Global Filgrastim Injection Sales Market Share Geographic Region (2019-2024)
    Table 29. Global Filgrastim Injection Revenue by Geographic Region (2019-2024) & ($ millions)
    Table 30. Global Filgrastim Injection Revenue Market Share by Geographic Region (2019-2024)
    Table 31. Global Filgrastim Injection Sales by Country/Region (2019-2024) & (KL)
    Table 32. Global Filgrastim Injection Sales Market Share by Country/Region (2019-2024)
    Table 33. Global Filgrastim Injection Revenue by Country/Region (2019-2024) & ($ millions)
    Table 34. Global Filgrastim Injection Revenue Market Share by Country/Region (2019-2024)
    Table 35. Americas Filgrastim Injection Sales by Country (2019-2024) & (KL)
    Table 36. Americas Filgrastim Injection Sales Market Share by Country (2019-2024)
    Table 37. Americas Filgrastim Injection Revenue by Country (2019-2024) & ($ Millions)
    Table 38. Americas Filgrastim Injection Revenue Market Share by Country (2019-2024)
    Table 39. Americas Filgrastim Injection Sales by Type (2019-2024) & (KL)
    Table 40. Americas Filgrastim Injection Sales by Application (2019-2024) & (KL)
    Table 41. APAC Filgrastim Injection Sales by Region (2019-2024) & (KL)
    Table 42. APAC Filgrastim Injection Sales Market Share by Region (2019-2024)
    Table 43. APAC Filgrastim Injection Revenue by Region (2019-2024) & ($ Millions)
    Table 44. APAC Filgrastim Injection Revenue Market Share by Region (2019-2024)
    Table 45. APAC Filgrastim Injection Sales by Type (2019-2024) & (KL)
    Table 46. APAC Filgrastim Injection Sales by Application (2019-2024) & (KL)
    Table 47. Europe Filgrastim Injection Sales by Country (2019-2024) & (KL)
    Table 48. Europe Filgrastim Injection Sales Market Share by Country (2019-2024)
    Table 49. Europe Filgrastim Injection Revenue by Country (2019-2024) & ($ Millions)
    Table 50. Europe Filgrastim Injection Revenue Market Share by Country (2019-2024)
    Table 51. Europe Filgrastim Injection Sales by Type (2019-2024) & (KL)
    Table 52. Europe Filgrastim Injection Sales by Application (2019-2024) & (KL)
    Table 53. Middle East & Africa Filgrastim Injection Sales by Country (2019-2024) & (KL)
    Table 54. Middle East & Africa Filgrastim Injection Sales Market Share by Country (2019-2024)
    Table 55. Middle East & Africa Filgrastim Injection Revenue by Country (2019-2024) & ($ Millions)
    Table 56. Middle East & Africa Filgrastim Injection Revenue Market Share by Country (2019-2024)
    Table 57. Middle East & Africa Filgrastim Injection Sales by Type (2019-2024) & (KL)
    Table 58. Middle East & Africa Filgrastim Injection Sales by Application (2019-2024) & (KL)
    Table 59. Key Market Drivers & Growth Opportunities of Filgrastim Injection
    Table 60. Key Market Challenges & Risks of Filgrastim Injection
    Table 61. Key Industry Trends of Filgrastim Injection
    Table 62. Filgrastim Injection Raw Material
    Table 63. Key Suppliers of Raw Materials
    Table 64. Filgrastim Injection Distributors List
    Table 65. Filgrastim Injection Customer List
    Table 66. Global Filgrastim Injection Sales Forecast by Region (2025-2030) & (KL)
    Table 67. Global Filgrastim Injection Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 68. Americas Filgrastim Injection Sales Forecast by Country (2025-2030) & (KL)
    Table 69. Americas Filgrastim Injection Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 70. APAC Filgrastim Injection Sales Forecast by Region (2025-2030) & (KL)
    Table 71. APAC Filgrastim Injection Revenue Forecast by Region (2025-2030) & ($ millions)
    Table 72. Europe Filgrastim Injection Sales Forecast by Country (2025-2030) & (KL)
    Table 73. Europe Filgrastim Injection Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 74. Middle East & Africa Filgrastim Injection Sales Forecast by Country (2025-2030) & (KL)
    Table 75. Middle East & Africa Filgrastim Injection Revenue Forecast by Country (2025-2030) & ($ millions)
    Table 76. Global Filgrastim Injection Sales Forecast by Type (2025-2030) & (KL)
    Table 77. Global Filgrastim Injection Revenue Forecast by Type (2025-2030) & ($ Millions)
    Table 78. Global Filgrastim Injection Sales Forecast by Application (2025-2030) & (KL)
    Table 79. Global Filgrastim Injection Revenue Forecast by Application (2025-2030) & ($ Millions)
    Table 80. Accord Healthcare Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
    Table 81. Accord Healthcare Filgrastim Injection Product Portfolios and Specifications
    Table 82. Accord Healthcare Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
    Table 83. Accord Healthcare Main Business
    Table 84. Accord Healthcare Latest Developments
    Table 85. Teva Pharmaceuticals Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
    Table 86. Teva Pharmaceuticals Filgrastim Injection Product Portfolios and Specifications
    Table 87. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
    Table 88. Teva Pharmaceuticals Main Business
    Table 89. Teva Pharmaceuticals Latest Developments
    Table 90. Pfizer Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
    Table 91. Pfizer Filgrastim Injection Product Portfolios and Specifications
    Table 92. Pfizer Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
    Table 93. Pfizer Main Business
    Table 94. Pfizer Latest Developments
    Table 95. Amgen Inc Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
    Table 96. Amgen Inc Filgrastim Injection Product Portfolios and Specifications
    Table 97. Amgen Inc Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
    Table 98. Amgen Inc Main Business
    Table 99. Amgen Inc Latest Developments
    Table 100. Novartis AG Basic Information, Filgrastim Injection Manufacturing Base, Sales Area and Its Competitors
    Table 101. Novartis AG Filgrastim Injection Product Portfolios and Specifications
    Table 102. Novartis AG Filgrastim Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
    Table 103. Novartis AG Main Business
    Table 104. Novartis AG Latest Developments
List of Figures
    Figure 1. Picture of Filgrastim Injection
    Figure 2. Filgrastim Injection Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Filgrastim Injection Sales Growth Rate 2019-2030 (KL)
    Figure 7. Global Filgrastim Injection Revenue Growth Rate 2019-2030 ($ Millions)
    Figure 8. Filgrastim Injection Sales by Region (2019, 2023 & 2030) & ($ Millions)
    Figure 9. Product Picture of 300mcg/mL (vial)
    Figure 10. Product Picture of 480mcg/1.6 mL (vial)
    Figure 11. Product Picture of 300mcg/0.5mL (Prefilled Syringe)
    Figure 12. Product Picture of 480mcg/0.8mL (Prefilled Syringe)
    Figure 13. Global Filgrastim Injection Sales Market Share by Type in 2023
    Figure 14. Global Filgrastim Injection Revenue Market Share by Type (2019-2024)
    Figure 15. Filgrastim Injection Consumed in Adult Use
    Figure 16. Global Filgrastim Injection Market: Adult Use (2019-2024) & (KL)
    Figure 17. Filgrastim Injection Consumed in Pediatric Use
    Figure 18. Global Filgrastim Injection Market: Pediatric Use (2019-2024) & (KL)
    Figure 19. Filgrastim Injection Consumed in Geriatric Use
    Figure 20. Global Filgrastim Injection Market: Geriatric Use (2019-2024) & (KL)
    Figure 21. Global Filgrastim Injection Sales Market Share by Application (2023)
    Figure 22. Global Filgrastim Injection Revenue Market Share by Application in 2023
    Figure 23. Filgrastim Injection Sales Market by Company in 2023 (KL)
    Figure 24. Global Filgrastim Injection Sales Market Share by Company in 2023
    Figure 25. Filgrastim Injection Revenue Market by Company in 2023 ($ Million)
    Figure 26. Global Filgrastim Injection Revenue Market Share by Company in 2023
    Figure 27. Global Filgrastim Injection Sales Market Share by Geographic Region (2019-2024)
    Figure 28. Global Filgrastim Injection Revenue Market Share by Geographic Region in 2023
    Figure 29. Americas Filgrastim Injection Sales 2019-2024 (KL)
    Figure 30. Americas Filgrastim Injection Revenue 2019-2024 ($ Millions)
    Figure 31. APAC Filgrastim Injection Sales 2019-2024 (KL)
    Figure 32. APAC Filgrastim Injection Revenue 2019-2024 ($ Millions)
    Figure 33. Europe Filgrastim Injection Sales 2019-2024 (KL)
    Figure 34. Europe Filgrastim Injection Revenue 2019-2024 ($ Millions)
    Figure 35. Middle East & Africa Filgrastim Injection Sales 2019-2024 (KL)
    Figure 36. Middle East & Africa Filgrastim Injection Revenue 2019-2024 ($ Millions)
    Figure 37. Americas Filgrastim Injection Sales Market Share by Country in 2023
    Figure 38. Americas Filgrastim Injection Revenue Market Share by Country in 2023
    Figure 39. Americas Filgrastim Injection Sales Market Share by Type (2019-2024)
    Figure 40. Americas Filgrastim Injection Sales Market Share by Application (2019-2024)
    Figure 41. United States Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 42. Canada Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 43. Mexico Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 44. Brazil Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 45. APAC Filgrastim Injection Sales Market Share by Region in 2023
    Figure 46. APAC Filgrastim Injection Revenue Market Share by Regions in 2023
    Figure 47. APAC Filgrastim Injection Sales Market Share by Type (2019-2024)
    Figure 48. APAC Filgrastim Injection Sales Market Share by Application (2019-2024)
    Figure 49. China Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 50. Japan Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 51. South Korea Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 52. Southeast Asia Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 53. India Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 54. Australia Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 55. China Taiwan Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 56. Europe Filgrastim Injection Sales Market Share by Country in 2023
    Figure 57. Europe Filgrastim Injection Revenue Market Share by Country in 2023
    Figure 58. Europe Filgrastim Injection Sales Market Share by Type (2019-2024)
    Figure 59. Europe Filgrastim Injection Sales Market Share by Application (2019-2024)
    Figure 60. Germany Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 61. France Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 62. UK Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 63. Italy Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 64. Russia Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 65. Middle East & Africa Filgrastim Injection Sales Market Share by Country in 2023
    Figure 66. Middle East & Africa Filgrastim Injection Revenue Market Share by Country in 2023
    Figure 67. Middle East & Africa Filgrastim Injection Sales Market Share by Type (2019-2024)
    Figure 68. Middle East & Africa Filgrastim Injection Sales Market Share by Application (2019-2024)
    Figure 69. Egypt Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 70. South Africa Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 71. Israel Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 72. Turkey Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 73. GCC Country Filgrastim Injection Revenue Growth 2019-2024 ($ Millions)
    Figure 74. Manufacturing Cost Structure Analysis of Filgrastim Injection in 2023
    Figure 75. Manufacturing Process Analysis of Filgrastim Injection
    Figure 76. Industry Chain Structure of Filgrastim Injection
    Figure 77. Channels of Distribution
    Figure 78. Global Filgrastim Injection Sales Market Forecast by Region (2025-2030)
    Figure 79. Global Filgrastim Injection Revenue Market Share Forecast by Region (2025-2030)
    Figure 80. Global Filgrastim Injection Sales Market Share Forecast by Type (2025-2030)
    Figure 81. Global Filgrastim Injection Revenue Market Share Forecast by Type (2025-2030)
    Figure 82. Global Filgrastim Injection Sales Market Share Forecast by Application (2025-2030)
    Figure 83. Global Filgrastim Injection Revenue Market Share Forecast by Application (2025-2030)

Companies Mentioned

Accord Healthcare

Teva Pharmaceuticals

Pfizer

Amgen Inc

Novartis AG

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff